Showing results (671-680 of 687) with videos related to
Sort By:
Pageof 69
Journal of Bone Oncology|July 2, 2026
LL-37 inhibits osteosarcoma progression by suppressing SQLE-mediated cholesterol synthesis via the PTEN/AKT/mTOR pathwayFatai Lu, Zhijun Liu, Huasheng Jiang, et al.Journal of Bone Oncology|June 30, 2026
Recent research progress on the etiology and pathogenesis of tumor-induced osteomalacia: A reviewShuzhong Liu, Jinyi Xing, An Song, et al.Journal of Bone Oncology|July 1, 2026
Incidence of malignant transformation in giant cell tumor of bone following denosumab therapy: a systematic review and meta-analysisIbrahim S Alshaygy, Mishari Alanezi, Omar Aldosari, et al.Journal of Bone Oncology|June 19, 2026
Lapatinib induces ferroptosis in osteosarcoma via the SLC1A5-GPX4 axisHaichuan Miao, Xijia Fu, Baolong Liu, et al.Journal of Bone Oncology|May 16, 2023
Molecular imaging of bone metastasisEliana Khojasteh, Farrokh Dehdashti, Monica ShokeenJournal of Bone Oncology|May 8, 2026
A review of spontaneous bone metastases in domestic and laboratory animalsShiyu Yuan, Nathan K Hoggard, Evan T Keller, et al.Journal of Bone Oncology|May 7, 2026
MiRNA-based expression signatures in differential diagnosis of enchondroma and chondrosarcomaAnnabell Walter, Kathrin Katenkamp, Nikolaus Gaßler, et al.Journal of Bone Oncology|May 11, 2026
Age-related real-world treatment patterns and outcomes of localised, high-grade osteosarcomaTomohiro Fujiwara, Shintaro Iwata, Akihito Nagano, et al.Journal of Bone Oncology|May 7, 2026
CDK4/6 inhibitor ribociclib and doxorubicin combination treatment inhibits breast cancer bone metastasis and enhances T-cell targeted therapyXinming Su, Takayuki Kobayashi, Jingyu Xiang, et al.Journal of Bone Oncology|July 28, 2026
Targeting the Hippo/YAP-TAZ pathway increases X-ray sensitivity in chondrosarcoma spheroids and is associated with autophagic disruptionBirgit Lohberger, Dietmar Glänzer, Heike Kaltenegger, et al.Pageof 69